Page 2 of 2

Synbio profile interview – Alison McLennan


McLennan1.jpgDr Alison McLennan is an Assistant Professor at Faculty of Business, Government and Law, University of Canberra. Alison is particularly interested in the challenges posed to regulation by emerging technologies, especially biotechnologies. Her PhD investigated regulation of synthetic biology and was awarded in 2014. In 2017, she presented the legal issues relating to synthetic biology at the SBA conference held in Sydney. She has continued to publish work on SynBio regulation and patent law, including for general audiences via The Conversation, and has a new book about synthetic biology law and policy issues coming out in 2018. Alison is interested in how we can not only manage the risks of new technologies, but also maximise their potential benefits. Twitter handle: @asmclennan

Continue reading → Synbio profile interview – Alison McLennan

CRISPR-Cas9 genome editing: from Cancer Treatment to Agriculture

by Jestin George

Crispr banner
CRISPR-Cas9 editing of the genome from NIH image gallery (Creative Commons CC2.0 from Flickr)

In 2012 the first evidence of CRISPR-Cas9 genome editing was published and since then, almost 4000 CRISPR-Cas9 articles have followed. From fundamental research to applications in biotechnology, agriculture, health care, pest control, and synthetic biology, there is no doubt that CRISPR systems will revolutionise both biological research and indeed, technology, as we know it. Continue reading → CRISPR-Cas9 genome editing: from Cancer Treatment to Agriculture

SBA signs MoU with Biotechnology and Biochemical Engineering Society of Taiwan

In the first of two important initiatives, SBA President Claudia Vickers recently signed a Memorandum of Understanding on behalf of SBA with Biotechnology and Bioengineering Society of Taiwan president Ching-Kuan Lin.

This MoU is designed to help facilitate cooperative collaboration between Taiwanese and Australian/New Zealand synthetic biologists. If you would like information or contacts for collaboration in Taiwan, please contact Claudia. This will be followed by a signing of an MoU between SBA and the Asian Federation of Biotechnolgy, scheduled to happen during the SB7.0 conference in Singapore.